BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20861336)

  • 1. Performance of genotypic algorithms for predicting HIV-1 tropism measured against the enhanced-sensitivity Trofile coreceptor tropism assay.
    Sánchez V; Masiá M; Robledano C; Padilla S; Ramos JM; Gutiérrez F
    J Clin Microbiol; 2010 Nov; 48(11):4135-9. PubMed ID: 20861336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.
    Sánchez V; Masiá M; Robledano C; Padilla S; Lumbreras B; Poveda E; De Mendoza C; Soriano V; Gutiérrez F
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):51-8. PubMed ID: 21068675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
    Mulinge M; Lemaire M; Servais JY; Rybicki A; Struck D; da Silva ES; Verhofstede C; Lie Y; Seguin-Devaux C; Schmit JC; Bercoff DP
    PLoS One; 2013; 8(5):e60566. PubMed ID: 23667426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
    McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
    Portsmouth S; Valluri SR; Däumer M; Thiele B; Valdez H; Lewis M; Craig C; Thielen A; James I; Demarest J; Heera J
    Antiviral Res; 2013 Jan; 97(1):60-5. PubMed ID: 23165088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.
    Weber J; Vazquez AC; Winner D; Gibson RM; Rhea AM; Rose JD; Wylie D; Henry K; Wright A; King K; Archer J; Poveda E; Soriano V; Robertson DL; Olivo PD; Arts EJ; Quiñones-Mateu ME
    J Clin Microbiol; 2013 May; 51(5):1517-27. PubMed ID: 23486708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.
    Recordon-Pinson P; Soulié C; Flandre P; Descamps D; Lazrek M; Charpentier C; Montes B; Trabaud MA; Cottalorda J; Schneider V; Morand-Joubert L; Tamalet C; Desbois D; Macé M; Ferré V; Vabret A; Ruffault A; Pallier C; Raymond S; Izopet J; Reynes J; Marcelin AG; Masquelier B;
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3335-40. PubMed ID: 20530226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients.
    Kagan RM; Johnson EP; Siaw M; Biswas P; Chapman DS; Su Z; Platt JL; Pesano RL
    PLoS One; 2012; 7(9):e46334. PubMed ID: 23029482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C viruses.
    Crous S; Shrestha RK; Travers SA
    BMC Infect Dis; 2012 Sep; 12():203. PubMed ID: 22938574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.
    Swenson LC; Moores A; Low AJ; Thielen A; Dong W; Woods C; Jensen MA; Wynhoven B; Chan D; Glascock C; Harrigan PR
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):506-10. PubMed ID: 20512044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.
    Wilkin TJ; Goetz MB; Leduc R; Skowron G; Su Z; Chan ES; Heera J; Chapman D; Spritzler J; Reeves JD; Gulick RM; Coakley E
    Clin Infect Dis; 2011 Apr; 52(7):925-8. PubMed ID: 21427401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the high prevalence of Dual/Mixed- or X4-tropism among HIV type 1 CRF01_AE in Hong Kong by genotyping and phenotyping methods.
    To SW; Chen JH; Wong KH; Chan KC; Chen Z; Yam WC
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1123-8. PubMed ID: 23647565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of population and 454 "deep" sequence analysis for HIV type 1 tropism versus the original trofile assay in non-B subtypes.
    Lee GQ; Harrigan PR; Dong W; Poon AF; Heera J; Demarest J; Rinehart A; Chapman D; Valdez H; Portsmouth S
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):979-84. PubMed ID: 23350534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.
    Prosperi MC; Bracciale L; Fabbiani M; Di Giambenedetto S; Razzolini F; Meini G; Colafigli M; Marzocchetti A; Cauda R; Zazzi M; De Luca A
    Retrovirology; 2010 Jun; 7():56. PubMed ID: 20591141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.
    Kagan RM; Johnson EP; Siaw MF; Van Baelen B; Ogden R; Platt JL; Pesano RL; Lefebvre E
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):151-9. PubMed ID: 23875707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
    Poveda E; Seclén E; González Mdel M; García F; Chueca N; Aguilera A; Rodríguez JJ; González-Lahoz J; Soriano V
    J Antimicrob Chemother; 2009 May; 63(5):1006-10. PubMed ID: 19261623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Genotypic Assay to Quantify CXCR4- and CCR5-Tropic Human Immunodeficiency Virus Type-1 (HIV-1) Populations and a Comparison to Trofile
    Ko D; McLaughlin S; Deng W; Mullins JI; Dragavon J; Harb S; Coombs RW; Frenkel LM
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.
    Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Encinas S; Sandres-Sauné K; Pasquier C; Marchou B; Massip P; Izopet J
    J Clin Microbiol; 2009 Jul; 47(7):2292-4. PubMed ID: 19439544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype.
    Soulié C; Fofana DB; Boukli N; Sayon S; Lambert-Niclot S; Wirden M; Simon A; Katlama C; Calvez V; Girard PM; Marcelin AG; Morand-Joubert L
    J Clin Virol; 2016 Mar; 76():51-4. PubMed ID: 26826578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.